Analyst consensus rating
Sabra Health Care REIT Analyst Rating: Buy
Direct answer
Sabra Health Care REIT's consensus rating is Buy.
14 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $22.79.
Forecast evidence checked September 5, 2026.
Get free Sabra Health Care REIT email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $20.78
- Average price target
- $22.79
- High price target
- $25.00
- Low price target
- $19.00
- Low target gap
- -8.6%
- Target upside
- +9.7%
- High target gap
- +20.3%
- Target range width
- 28.9%
- Consensus rating
- Buy
- Analysts
- 14
- Evidence date
- September 5, 2026
- Valid through
- September 12, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Sabra Health Care REIT?
Sabra Health Care REIT has a verified Buy consensus. The same dataset has an average price target of $22.79.
How far are Sabra Health Care REIT's low and high targets from the recorded price?
The low target implies -8.6%, while the high target implies +20.3%.
How many analysts are included in Sabra Health Care REIT's consensus?
The verified consensus includes 14 analysts.
How is Sabra Health Care REIT's target upside or downside calculated?
The average target of $22.79 is divided by the recorded price of $20.78, then one is subtracted to produce +9.7%. This does not guarantee a future return.
When was Sabra Health Care REIT's analyst forecast verified?
The data was verified on 2026-09-05. The dataset is valid through 2026-09-12.